Logo do repositório
 
Publicação

Progress in identifying the preventable causes of human cancer

dc.contributor.authorSchubauer-Berigan, Mary K.
dc.contributor.authorMadia, Federica
dc.contributor.authorKunzmann, Andrew T.
dc.contributor.authorBenbrahim-Tallaa, Lamia
dc.contributor.authorde Conti, Aline
dc.contributor.authorFacchin, Caterina
dc.contributor.authorPasqual, Elisa
dc.contributor.authorWedekind, Roland
dc.contributor.authorDeng, Xiaobei
dc.contributor.authorSuonio, Eero
dc.contributor.authorViegas, Susana
dc.contributor.authorMattock, Heidi
dc.contributor.authorWeiderpass, Elisabete
dc.contributor.institutionEscola Nacional de Saúde Pública (ENSP)
dc.contributor.pblOxford University Press
dc.date.accessioned2026-06-12T09:43:01Z
dc.date.available2026-06-12T09:43:01Z
dc.date.issued2026-04
dc.descriptionPublisher Copyright: © The Author(s) 2026. Published by Oxford University Press. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
dc.description.abstractFor 54 years, the Monographs program of the International Agency for Research on Cancer has evaluated the carcinogenicity of agents suspected of causing cancer in humans, classifying them into categories according to strength of the scientific evidence. More than 15 years ago, all Group 1 agents (carcinogenic to humans, the highest strength-of-evidence category) were re-evaluated. Since then, 24 additional agents have been classified for the first time in Group 1. Here, we summarize the evidence for the 135 Group 1 agents, emphasizing those recently classified and providing a synthetic overview of the evidence that contributed to the classification. All but two of these newly identified Group 1 agents were found to have sufficient evidence for one or more cancer types in humans, most commonly cancers of lung, hematolymphoid tissue, skin, and urinary bladder. Perfluorooctanoic acid and “dioxin-like” polychlorinated biphenyls were classified in Group 1 with less than sufficient evidence for cancer in humans. For nearly all Group 1 agents, there was also sufficient evidence for cancer in experimental animals, strong mechanistic evidence, or both, illustrating the robust biological plausibility of Group 1 classifications. This survey of the known human carcinogens confirms that there are few established preventable causes for 3 of the 4 most common cancer types (breast, prostate, and colorectum) and for reproductive cancers in both women and men. Over the last 15 years, the number of known human carcinogens has increased by >20%, reflecting the continued advancement of evidence and implying the existence of as yet unrecognized, preventable causes of cancer.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent8
dc.format.extent3277791
dc.identifier.doi10.1093/jncimonographs/lgaf039
dc.identifier.issn1052-6773
dc.identifier.otherPURE: 164596716
dc.identifier.otherPURE UUID: 62dd9923-555f-48c6-8466-00fc4bc551b1
dc.identifier.otherScopus: 105036254335
dc.identifier.otherPubMed: 42008728
dc.identifier.otherPubMedCentral: PMC13094941
dc.identifier.urihttp://hdl.handle.net/10362/203752
dc.identifier.urlhttps://www.scopus.com/pages/publications/105036254335
dc.language.isoeng
dc.peerreviewedyes
dc.subjectOncology
dc.subjectCancer Research
dc.subjectSDG 3 - Good Health and Well-being
dc.titleProgress in identifying the preventable causes of human canceren
dc.title.subtitlethe experience of the IARC Monographs programen
dc.typejournal article
degois.publication.firstPage78
degois.publication.issue72
degois.publication.lastPage85
degois.publication.titleJournal of the National Cancer Institute - Monographs
degois.publication.volume2026
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
SchubauerBerigan_2026_J_Nat_Cancer_Inst_Monog_72_78.pdf
Tamanho:
3.13 MB
Formato:
Adobe Portable Document Format